Pharmacokinetics, pharmacodynamics, safety and tolerability of 4 weeks' treatment with empagliflozin in Japanese patients with type 2 diabetes mellitus

著者: Kanada, Shigeto, Koiwai, Kazuki, Taniguchi, Atsushi, Sarashina, Akiko, Seman, Leo, Woerle, Hans J
出版事項 2013

Comparable pharmacodynamics, efficacy, and safety of linagliptin 5 mg among Japanese, Asian and white patients with type 2 diabetes

著者: Sarashina, Akiko, Friedrich, Christian, Crowe, Susanne, Patel, Sanjay, Graefe‐Mody, Ulrike, Hayashi, Naoyuki, Horie, Yoshiharu
出版年 J Diabetes Investig (2016)

Empagliflozin as adjunct to insulin in Japanese participants with type 1 diabetes: Results of a 4‐week, double‐blind, randomized, placebo‐controlled phase 2 trial

著者: Shimada, Akira, Hanafusa, Toshiaki, Yasui, Atsutaka, Lee, Ganghyuck, Taneda, Yusuke, Sarashina, Akiko, Shiki, Kosuke, George, Jyothis, Soleymanlou, Nima, Marquard, Jan
出版年 Diabetes Obes Metab (2018)

Population pharmacokinetics of tamsulosin hydrochloride in paediatric patients with neuropathic and non-neuropathic bladder

著者: Tsuda, Yasuhiro, Tatami, Shinji, Yamamura, Norio, Tadayasu, Yusuke, Sarashina, Akiko, Liesenfeld, Karl-Heinz, Staab, Alexander, Schäfer, Hans-Günter, Ieiri, Ichiro, Higuchi, Shun
出版事項 2010

Phase I Study of the Focal Adhesion Kinase Inhibitor BI 853520 in Japanese and Taiwanese Patients with Advanced or Metastatic Solid Tumors

著者: Doi, Toshihiko, Yang, James Chih-Hsin, Shitara, Kohei, Naito, Yoichi, Cheng, Ann-Lii, Sarashina, Akiko, Pronk, Linda C., Takeuchi, Yoshito, Lin, Chia-Chi
出版年 Target Oncol (2019)

An open-label feasibility study of nintedanib combined with docetaxel in Japanese patients with locally advanced or metastatic lung adenocarcinoma after failure of first-line chemo...

著者: Yamamoto, Noboru, Kenmotsu, Hirotsugu, Goto, Koichi, Takeda, Koji, Kato, Terufumi, Takeda, Masayuki, Horinouchi, Hidehito, Saito, Isao, Sarashina, Akiko, Tanaka, Tetsuya, Morsli, Nassim, Nakagawa, Kazuhiko
出版年 Cancer Chemother Pharmacol (2018)